Cargando…
Comment to Sands et al. — No clinical benefit in mortality associated with hydroxychloroquine treatment in patients with COVID-19
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903151/ https://www.ncbi.nlm.nih.gov/pubmed/33639295 http://dx.doi.org/10.1016/j.ijid.2021.02.079 |
| _version_ | 1783654678598254592 |
|---|---|
| author | Hoang, Van Thuan |
| author_facet | Hoang, Van Thuan |
| author_sort | Hoang, Van Thuan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7903151 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-79031512021-02-24 Comment to Sands et al. — No clinical benefit in mortality associated with hydroxychloroquine treatment in patients with COVID-19 Hoang, Van Thuan Int J Infect Dis Letter to the Editor The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021-04 2021-02-24 /pmc/articles/PMC7903151/ /pubmed/33639295 http://dx.doi.org/10.1016/j.ijid.2021.02.079 Text en © 2021 The Author(s) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Hoang, Van Thuan Comment to Sands et al. — No clinical benefit in mortality associated with hydroxychloroquine treatment in patients with COVID-19 |
| title | Comment to Sands et al. — No clinical benefit in mortality associated with hydroxychloroquine treatment in patients with COVID-19 |
| title_full | Comment to Sands et al. — No clinical benefit in mortality associated with hydroxychloroquine treatment in patients with COVID-19 |
| title_fullStr | Comment to Sands et al. — No clinical benefit in mortality associated with hydroxychloroquine treatment in patients with COVID-19 |
| title_full_unstemmed | Comment to Sands et al. — No clinical benefit in mortality associated with hydroxychloroquine treatment in patients with COVID-19 |
| title_short | Comment to Sands et al. — No clinical benefit in mortality associated with hydroxychloroquine treatment in patients with COVID-19 |
| title_sort | comment to sands et al. — no clinical benefit in mortality associated with hydroxychloroquine treatment in patients with covid-19 |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903151/ https://www.ncbi.nlm.nih.gov/pubmed/33639295 http://dx.doi.org/10.1016/j.ijid.2021.02.079 |
| work_keys_str_mv | AT hoangvanthuan commenttosandsetalnoclinicalbenefitinmortalityassociatedwithhydroxychloroquinetreatmentinpatientswithcovid19 |